Cleared Traditional

Patient Monitor, models LMPLUS-12, LMPLUS-15 and LMPLUS-17 (K221616) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K221616 · Caf Medical Solutions, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2022
Decision
59d
Days
Class 2
Risk

K221616 is an FDA 510(k) clearance for the Patient Monitor, models LMPLUS-12, LMPLUS-15 and LMPLUS-17. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Caf Medical Solutions, Inc. (Hockley, US). The FDA issued a Cleared decision on August 1, 2022 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Caf Medical Solutions, Inc. devices

Submission Details

510(k) Number K221616 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 2022
Decision Date August 01, 2022
Days to Decision 59 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 125d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Compliance4Devices
Juan Tezak

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 168
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K221616.
EK12 V2 Algorithm
K221904 · Ge Medical Systems Information Technologies, Inc. · Dec 2022
Patient Monitor: RespArray
K220308 · Edan Instruments, Inc. · Aug 2022
Patient Monitor, models LM-8, LM-10, LM-12 and LM-15
K221879 · Caf Medical Solutions, Inc. · Aug 2022
Next Generation NetKonnect
K220989 · Nihon Kohden Digital Health Solutions, Inc. · Jul 2022
N Series Patient Monitors
K213799 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jul 2022
CARESCAPE B650, E-musb
K213181 · GE Healthcare Finland Oy · Apr 2022